Experience with intraaortic balloon counterpulsation.

P. Sanfelippo,N. H. Baker,H. G. Ewy,P. J. Moore,J. W. Thomas,G. J. Brahos,R. F. McVicker

DOI: https://doi.org/10.1016/S0003-4975(10)64493-1

Abstract:

What problem does this paper attempt to address?

Application of intraaortic balloon counterpulsation during primary percutaneous coronary intervention in patients with cardiogenic shock complicating with acute myocardial infarction

Ying ZHU,Mei-xiang XIANG,Ji MA,Jian-an WANG

DOI: https://doi.org/10.3760/j.issn:1671-0282.2007.12.006

2007-01-01

Abstract:Objective: To investigate the safety, efficacy and effects of emergent percutaneous coronary intervention (PCI) in patients from Second Affiliated Hospital, Medical College, Zhejiang University with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). Method: Twenty-seven patients with CS complicating with AMI were treated by PCI with intraaortic balloon counterpulsation (IABP) support. The change of hemodynamics before and after IABP and PCI, the characteristics of PCI, the mortality during hospitalization, the major adverse cardiac events (MACE) and left ventricular ejection fraction at 30 - day follow - up were observed. Results: The hemodynamics were significantly improved after IABP. No patients died during PCI. Two patients died after PCI and the total mortality was 7.4% in hospital. During the period of 30 - day follow - up, one patient died of heart failure. The left ventricular ejection fraction greatly improved at 30 days after PCI. Conclusions: The data suggested that the use of IABP during PCI in patients with CS complicating AMI was safe, decreased mortality and improved prognosis.
Clinical evaluation of intra aortic balloon couterpulsation in percutaneous coronary interention for patients with acute myocardial infarction combined with cardiogenic shock

ZHU Jihong

IF: 5.41

2010-01-01

Clinical Medicine

Abstract:Objective To evaluate the therapeutic effect of intra-aortic balloon couterpulsation in percutaneous coronary in-tervention for patients with acute myocardial infarction combined with cardiogenic shock. Methods Fifty-two AMI patients combined with CS diagnosed were treated with a verdict by the IABP circulatory support emergency treatment,with the same period,48 patients of the same disease without IABP treatment as a control group to compare. Application of PCI treatment in both groups on the basis of conventional medication. Before and after IABP that were observed in patients with cardiac function,fatality after one week of PCI and the incidence of vascular re -occlusion. Results Neice radial artery diastolic pressure,MAP,CI,CO,SV and EF in the treatment group were significantly higher than that before operation ( P < 0. 05 or P < 0. 05),while PCWP was significantly lower than that before operation ( P < 0. 05),the mortality of treatment group was significantly lower than that in the control group ( P < 0. 05),the incidence rate of vessel re -occlusion in treatment group was significantly lower than that in the control group ( P < 0. 05). Conclusion IABP can significantly improve cardiac function and reduce mortality in patients with AMI complicated with CS and reduce the rate of vessel reocclusion.
Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications

L. X. van Nunen,M. van ’t Veer,S. Schampaert,B. J. E. M. Steerneman,M. C. M. Rutten,F. N. van de Vosse,N. H. J. Pijls

DOI: https://doi.org/10.1007/s12471-013-0485-9

2013-10-30

Netherlands Heart Journal

Abstract:BackgroundRecent evidence questions the role of intra-aortic balloon counterpulsation (IABP) in the treatment of acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). An area of increasing interest is the use of IABP for persistent ischaemia (PI). We analysed the use of IABP in patients with AMI complicated by CS or PI.MethodsFrom 2008 to 2010, a total of 4076 patients were admitted to our hospital for primary percutaneous coronary intervention (PCI) for AMI. Out of those, 239 patients received an IABP either because of CS or because of PI. Characteristics and outcome of those patients are investigated.ResultsThe mean age of the study population was 64 ± 11 years; 75 % were male patients. Of the patients, 63 % had CS and 37 % had PI. Patients with CS had a 30-day mortality rate of 36 %; 1-year mortality was 41 %. Patients with PI had a 30-day mortality rate of 7 %; 1-year mortality was 11 %.ConclusionsMortality in patients admitted for primary PCI because of AMI complicated by CS is high despite IABP use. Outcome in patients treated with IABP for PI is favourable and mandates further prospective studies.

cardiac & cardiovascular systems
Aortic counterpulsation in cardiogenic shock during acute myocardial infarction

Andrea Rognoni,Chiara Cavallino,Alessandro Lupi,Alessia Veia,Roberta Rosso,Francesco Rametta,Angelo Sante Bongo

DOI: https://doi.org/10.1586/14779072.2014.921116

2014-05-21

Expert Review of Cardiovascular Therapy

Abstract:Intra-aortic balloon counterpulsation is the most widely used form of mechanical hemodynamic support in the setting of cardiogenic shock due to ST-segment elevation myocardial infarction (STEMI). Intra-aortic balloon pump (IABP) is also strongly recommended (class 1b) in the current European guidelines for treatment of STEMI. The evidence of a possible benefit of IABP in this setting is based mainly on registry data and a few randomized trials. Cardiogenic shock and subsequent death due to STEMI result from three factors: hemodynamic deterioration, occurrence of multiorgan dysfunction and systemic inflammatory response. IABP does not cause an immediate improvement in blood pressure, but the recent SHOCK II trial shows positive effects on multiorgan dysfunction. Some experimental and clinical studies have indicated that IABP results in hemodynamic benefits as a result of afterload reduction and diastolic augmentation with improvement of coronary perfusion. However, the effect on cardiac output is modest and may not be sufficient to reduce mortality. Furthermore we can say that the use of IABP before coronary revascularization in the setting of STEMI complicated with cardiogenic shock may make the interventional procedure safer by improving left ventricular unloading. The purpose of the present review is to clarify the state of the art on this topic.
Clinical analysis of 33 patients with acute myocardial infarction implanted with intra-aortic balloon counterpulsation

WANG Xiangfei,WANG Qibing,GE Lei,QIAN Juying,ZHANG Feng,YAN Yan,LIU Xuebo,GE Junbo

2010-01-01

Abstract:Objective To analyze the clinical data of 33 patients with acute myocardial infarction (AMI) implanted with intra-aortic balloon counterpulsation (IABP),so as to study the application of IABP. Methods The clinical data of 33 myocardial infarction patients implanted with IABP were reviewed retrospectively. Results Twenty-seven (82%) of the patients were male; the mean age of patients was (68.9±11.3) years old. Twenty-two patients had anterior infarction and 8 had inferior infarction. All-cause mortality was 64% (21/33). Seventeen patients achieved stable hemodynamic situation,then with intra-aotic balloon removed successfully; however,five of them finally died from other complicating diseases. The median duration of IABP support was 48 hours. Six patients had received prompt bedside insertion without any severe complications. Eigth patients had acute renal failure or acute aggravation of chronic renal failure and 6 of them died. Conclusion Although most of the patients assisted by IABP support can achieve stable hemodynamics,the in-hospital mortality remains high. The implantation of IABP at bedside is feasible.
A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery

Sagar Sharma,Jie Hui Nah,Venkateswaran Siddarth,Haoxing Lai,Shen Liang,Zhi Xian Ong,Duoduo Wu,Haidong Luo,Guohao Chang,Giap Swee Kang,Theo Kofidis,Faizus Sazzad

DOI: https://doi.org/10.1038/s41598-024-81056-z

IF: 4.6

2024-11-29

Scientific Reports

Abstract:Background The use of intraaortic balloon pump (IABP) effectively reduces left ventricular afterload and significantly increases coronary perfusion pressure by raising aortic diastolic pressure. This study examined the short and medium-term outcomes of 22,540 adult cardiac surgical patients requiring an IABP. Methods From 2009 to 2018, 1114 patients (4.94%) undergoing open-heart surgery at a single tertiary cardiac hospital received IABP support and were included in this retrospective study. They were categorized into pre-operative (Group A, n = 577), intra-operative (Group B, n = 475), and post-operative (Group C, n = 62) IABP insertion groups. Results Cardiogenic shock occurred in 11.2% of cases, mainly in Group A. Hemodynamic instability (38.8%) drove IABP use in Groups A and C, while difficulty weaning from CPB was the primary reason in Group C. The overall operative mortality rate was 10.9%, highest at 25.8% postoperatively. Multivariate analysis identified significant predictors of mortality: age (OR: 1.067, 95% CI: 1.041–1.094, p < 0.001), higher BMI (OR: 1.071, 95% CI: 1.017–1.128, p = 0.009), pulmonary hypertension (OR: 2.085, 95% CI: 1.302–3.341, p = 0.002), renal disease (OR: 2.780, 95% CI: 1.556–4.967, p < 0.001), and cardiogenic shock (OR: 3.684, 95% CI: 2.066–6.569, p < 0.001). Complications were more common in Group C, especially with renal disease. Average preoperative and postoperative stays were 4.0 ± 4.8 days and 15.2 ± 20.4 days, respectively, with no significant differences between groups. Conclusion IABP might offer safety for open-heart surgery, with longer hospital stays potentially associated with high-risk patients. Pre-operative IABP prophylaxis could be crucial in high-risk open-heart cases to reduce mortality.

multidisciplinary sciences
Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Dingfeng Fang,Dongdong Yu,Jiabin Xu,Wei Ma,Yuxiang Zhong,Haibo Chen

DOI: https://doi.org/10.1186/s12872-023-03465-8

IF: 2.174

2023-08-30

BMC Cardiovascular Disorders

Abstract:The role of intra-aortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction (AMI) is still a subject of intense debate. In this study, we aim to investigate the effect of IABP on the clinical outcomes of patients with AMI complicated by cardiogenic shock undergoing percutaneous coronary intervention (PCI).

cardiac & cardiovascular systems
The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study

Wenjun Wang,Feifei Yang,Xixiang Lin,Qin Zhong,Zongren Li,Xu Chen,Junfeng Wang,Kunlun He

DOI: https://doi.org/10.1155/2021/6656926

2021-01-20

BioMed Research International

Abstract:Backgrounds. Intra-aortic balloon counterpulsation is increasingly used in acute myocardial infarction complicated by cardiogenic shock. The aim of this study was to explore the preference, effect, and prognosis of intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock patients. Methods. Data of acute myocardial infarction complicated by cardiogenic shock patients at the Fourth Medical Center of PLA General Hospital were collected retrospectively. A propensity score was calculated with a logistic regression which contained clinically meaningful variables and variables selected by Lasso and then used to match the control group. The cumulative incidence curve and Gray’s test were employed to analyse the effect and prognosis of intra-aortic balloon counterpulsation on mortality. Results. A total of 1962 acute myocardial infarction cases admitted between May 2015 and November 2018 were identified, and 223 cases with acute myocardial infarction complicated by cardiogenic shock were included as the study cohort, which contained 34 cases that received IABP and 189 cases that did not receive IABP. Patients with higher alanine aminotransferase ( OR = 1.93 , 95% CI 1.29-2.98), higher triglyceride ( OR = 3.71 , 95% CI 1.87-7.95), and higher blood glucose ( OR = 1.08 , 95% CI 0.99-1.18) had a higher probability of receiving intra-aortic balloon counterpulsation. In the propensity score matching analysis, 34 cases received intra-aortic balloon counterpulsation and 102 matched controls were included in the comparison. By comparing the cumulative incidence of in-hospital mortality, there was no statistically significant difference between the intra-aortic balloon counterpulsation group and matched control group ( P = 0.454 ). Conclusion. The use of intra-aortic balloon counterpulsation may not improve the prognosis of the acute myocardial infarction complicated by cardiogenic shock patients.

biotechnology & applied microbiology,medicine, research & experimental
Intra-aortic balloon pump: Looking at the other side

Sandro Gelsomino,Monique M J de Jong

DOI: https://doi.org/10.1111/aor.13797

Abstract:Intra-aortic balloon pump has been the most commonly employed cardiac assist device in the past, although, in recent years, its use in cardiogenic shock has been questioned. The pathophysiology of the proximal part of the balloon has been well studied, whereas, hemodynamics and flow below the distal portion of the balloon have not been fully understood yet. The distal flow contains a three-wave flow pattern during diastolic balloon expansion: a flow reduction in early diastole, a backflow in mid-diastole followed by a tele-diastolic flow. More research on this topic is warranted to better understand the physics of the distal part of the balloon and its interaction with the three components of the local regulatory system: intrinsic (local metabolic and myogenic), extrinsic (autonomic nervous system), and humoral (local or circulating vasoactive substances). These new insights will be a guide for new balloon designs that will allow enhanced performance and improved outcomes.
Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment.

Claudio De Lazzari,Beatrice De Lazzari,Attilio Iacovoni,Silvia Marconi,Silvia Papa,Massimo Capoccia,Roberto Badagliacca,Carmine Dario Vizza

DOI: https://doi.org/10.1016/j.cmpb.2020.105537

IF: 6.1

2020-10-01

Computer Methods and Programs in Biomedicine

Abstract:Background and Objective: The intra-aortic balloon pump (IABP) is the most widely available device for short-term mechanical circulatory support, often used to wean off cardiopulmonary bypass or combined with extra-corporeal membrane oxygenation support or as a bridge to a left ventricular assist device. Although based on a relatively simple principle, its complex interaction with the cardiovascular system remains challenging and open to debate. The aim of this work was focused on the development of a new numerical model of IABP.Methods: The new module was implemented in CARDIOSIM©, which is a modular software simulator of the cardiovascular system used in research and e-learning environment. The IABP is inserted into the systemic bed divided in aortic, thoracic and two abdominal tracts modelled with resistances inertances and compliances. The effect induced by the balloon is reproduced in each tract of the aorta by the presence of compliances connected to PIABP generator and resistances. PIABP generator reproduces the balloon pressure with the option to change IABP timing.We have used literature data to validate the potential of this new numerical model.Results: The results have shown that our simulation reproduced the typical effects induced during IABP assistance. We have also simulated the effects induced by the device on the hemodynamic variables when the IABP ratio was set to 1:1, 1:2, 1:4 and 1:8. The outcome of these simulations is in accordance with literature data measured in the clinical environment.Conclusions: The new IABP module is easy to manage and can be used as a training tool in a clinical setting. Although based on literature data, the outcome of the simulations is encouraging. Additional work is ongoing with a view to further validate its features. The configuration of CARDIOSIM© presented in this work allows to simulate the effects induced by mechanical ventilatory assistance. This facility may have significant importance in the management of patients affected by COVID-19 when they require mechanical circulatory support devices.

engineering, biomedical,computer science, interdisciplinary applications,medical informatics, theory & methods
Intraoperative intra-aortic balloon pump insertion: step by step

Carla Gotsens-Asenjo,Constanza Fernández-De Vinzenzi,Elena Roselló-Díez,César Piedra,Marta Molina,Juan Francisco Tabilo,Manel Tauron,Sandra Casellas,Ángela Irabién,Laura Corominas,Antonino Ginel,Jose Montiel

DOI: https://doi.org/10.1510/mmcts.2024.066

2024-10-18

Abstract:A 76-year-old patient with non-ST elevation myocardial infarction was admitted to our hospital. Coronary angiography revealed significant left main and two-vessel coronary artery disease. Preoperative testing indicated severe left ventricular dysfunction. The patient was scheduled for urgent off-pump coronary artery bypass grafting. Due to the low ejection fraction, an intra-aortic balloon pump was inserted in the operating theatre before sternotomy, to enhance the patient's haemodynamic stability during surgery. A 6 Fr introducer was inserted into the femoral artery under echocardiographic guidance. Using a 150-cm guidewire, the intra-aortic balloon catheter was advanced through the introducer to the descending thoracic aorta. The catheter's tip position, just distal to the origin of the left subclavian artery, was confirmed via transoesophageal echocardiography. The external part of the catheter was secured to the skin and connected to the balloon console. Therapy was initiated, and the inflation/deflation parameters were optimized. A double off-pump coronary artery bypass was performed via median sternotomy. The patient remained haemodynamically stable throughout the surgery, aided by the intra-aortic balloon pump, and careful volume and vasoactive management. The patient was extubated promptly, and the device was removed on the second postoperative day without complications.
Staying in touch with methylphenidate: AHDH and sensory processing. Focus on "methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats".

A. Arnsten,S. Vijayraghavan

DOI: https://doi.org/10.1152/JN.00373.2006

2006-08-01

Journal of Neurophysiology

Abstract:Drouin et al. (this issue of J. Neurophysiol. p. 622–632) provide the first analysis of the neurochemical and neurophysiological effects of the stimulant medication, methylphenidate (MPH), in sensory cortex of freely behaving animals. MPH has been prescribed to children and adults with Attention
Protracted aortic valve closure during peripheral veno-arterial extracorporeal life support: is intra-aortic balloon pump an effective solution?

Paolo Meani,Thijs Delnoij,Giuseppe M. Raffa,Nuccia Morici,Giovanna Viola,Alice Sacco,Fabrizio Oliva,Sam Heuts,Jan-Willem Sels,Rob Driessen,Paul Roekaerts,Martijn Gilbers,Elham Bidar,Rick Schreurs,Ehsan Natour,Leo Veenstra,Suzanne Kats,Jos Maessen,Roberto Lorusso

DOI: https://doi.org/10.1177/0267659118787426

2018-07-19

Perfusion

Abstract:Background: Left ventricular (LV) afterload increase with protracted aortic valve (AV) closure may represent a complication of veno-arterial extracorporeal membrane oxygenation (V-A ECMO). The aim of the present study was to assess the effects of an intra-aortic balloon pump (IABP) to overcome such a hemodynamic shortcoming in patients submitted to peripheral V-A ECMO. Methods: Among 184 adult patients who were treated with peripheral V-A ECMO support at Medical University Center Maastricht Hospital between 2007 and 2018, patients submitted to IABP implant for protracted AV closure after V-A ECMO implant were retrospectively identified. All clinical and hemodynamic data, including echocardiographic monitoring, were collected and analyzed. Results: During the study period, 10 subjects (mean age 60 years old, 80% males) underwent IABP implant after peripheral V-A ECMO positioning due to the diagnosis of protracted AV closure and inefficient LV unloading as assessed by echocardiography and an absence of pulsation in the arterial pressure wave. Recovery of blood pressure pulsatility and enhanced LV unloading were observed in 8 patients after IABP placement, with no significant differences in the main hemodynamic parameters, inotropic therapy or in the ECMO flow (p=0.48). The weaning rate in this patient subgroup (mean ECMO duration 8 days), however, was only 10%, with another patient finally transplanted, leading to a 20% survival-to-hospital discharge. Conclusion: IABP placement was an effective solution in order to reverse the protracted AV closure and impaired LV unloading observed during peripheral V-A ECMO support. However, the impact on the weaning rate and survival needs further investigations.
Salutary Effects of the PULVAD, a Novel Implantable Counterpulsation Assist Device, on Cardiac Mechanoenergetics

Christos Kontogiannis,Dionysios Aravantinos,Ioannis Nanas,Chris J Kapelios,Sotirios Marinakis,Styliani Vakrou,Smaragdi Sarchosi,Despina N Perrea,Jay W Mason,John N Nanas,Konstantinos Malliaras

DOI: https://doi.org/10.1097/MAT.0000000000000838

Abstract:The Pressure Unloading Left Ventricular Assist Vevice (PULVAD) is a novel implantable counterpulsation LVAD, designed to provide ventricular unloading with augmentation of LV performance and retention of pulsatility. We assessed the effects of the PULVAD on hemodynamics and LV mechanoenergetics in seven farm pigs with acute ischemic heart failure. The PULVAD was implanted in the thorax and was connected to the ascending aorta. The PULVAD was pneumatically driven by a standard intra-aortic balloon pump console and was electrocardiogram-synchronized to provide LV pressure unloading along with diastolic aortic pressure augmentation. Hemodynamics, indices of LV mechanoenergetics, and coronary blood flow were measured without and after brief PULVAD support. PULVAD support decreased LV afterload and improved LV mechanical performance (increased ejection fraction, stroke volume, cardiac output and maximum elastance). The PULVAD concurrently reduced LV energy consumption (decreased stroke work and pressure-volume area) and optimized LV energetic performance (improved the ratio of stroke work to pressure-volume area). PULVAD support increased mean coronary blood flow, through dramatic augmentation of diastolic blood flow. In conclusion, the PULVAD unloads the failing LV, optimizes LV mechanoenergetics, and augments coronary blood flow. These salutary effects of short-term PULVAD support provide the foundation for long-term testing.
Application of intra-aortic balloon pump in acute myocardial infarction complicared with cardiogenic shock undergoing percutaneous coronary intervention

Cheng-bi WANG,Jun GU,Wei HU,Hong-bing XIAO,Xiao-di FENG,Qiang YU,Xian JIN,Gui-zhi YIN,Cheng-jun CHEN,Yue-guang CHEN,Da-dong ZHANG

DOI: https://doi.org/10.3969/j.issn.1008-794X.2008.10.004

2008-01-01

Abstract:Objective: To analyze and evaluate the role of intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) undergoing percutaneous coronary intervention. Methods: The clinical data of 36 patients with AMI complicated by CS from January 1st 2003 to December 31st 2007 were collected. The treatment effects of IABP were analyzed with statistical methods. Results: IABP threatment can markedly restore heart rate and blood pressure, with stable short-term condition of the patient reaching 50%. The mortalities of 30-day and 3-month were 41.7% and 47.2%, respectively. Conclusion: Application of IABP in AMI complicated by CS undergoing PCI is safe and effective.
Clinical Application of Intra-Aortic Balloon Counterpulsation in Patients with Acute Myocardial Infarction

ZHANG Yao-jun,CHEN Shao-liang,TIAN Nai-liang,ZHANG Juan,GE Zhen,WANG Hai-yan,XIE Du-jiang,XIAO Ping-xi

DOI: https://doi.org/10.3760/cma.j.issn.1008-6315.2009.01.013

2010-01-01

Abstract:Objective To observe the application of intra-aortic balloon counterpulsation(IABP)in patients with acute myocardial infarction(AMI).Methods 1206 eases of AMI were selected consecutively.505 cases received successful reperfusion therapy and 701 cases received medical conservative therapy.464 cases were with anterior infarction,474 cases with inferior/posterior infarction and 268 cases with non-ST elevated MI(NSTEMI).There were 89 cases with cardiogenic shock(CS).Intra-aortic balloon pump(IABP)was used in patients accompanied with CS.cardiac rupture or papillary muscle dysfunction,left main or three vessel lesions with hemodynamic stability,pulmonary edema or ventficular arrhythmia in the course of PCI.Patients with IABP were divided into two groups according to juncture of IABP,early group(IABP was used in hemodynamic stability or within 1 hour of CS)and late group(IABP was used in hemodynamic instability or after 1 hour of CS).Results ①IABP was used in 97 patients.CS accounted for 45.3%(44/97),high risk PCI took 21.7%(21/97),hemodynamic instability was 15.5%(15/97).Mean duration of IABP insertion was 3.8 days.②In patients with IABP,successful reperfusion of death group[45.7%(16/35)vs 66.1%(41/62),P=0.041]and early IABP insertion group[25.7%(9/35)vs 91.9%(57/62),P=0.000]were fewer than that of survival.Accompanied with Cs[82.9%(29/35)vs 24.2%(15/62),P=0.000],cardiac rupture[20%(7/35)vs 0(0/62),P=0.000],urea nitrogen[(8.8±2.4)mmol/Lvs(6.3±1.0)mmol/L,P=0.040]and creatinine[(132.6±35.4)umol/L vs(79.6±17.7)μmol/L,P=0.000)]of death group were higher than that of survival.③Logistic regression analysis showed that CS(OR=0.066,CI 0.018-0.241,P=0.000)and juncture of using IABP(OR=0.219,CI 0.062-0.778,P=0.019)were the independent risk factors for death.Conclusion Using IABP earlier in high risk patients with AMI may reduce in-hospital mortality.
[The Effect of Intra-Aortic Balloon Pumping in Case of Left Main Coronary Artery Stenosis].

S Lu,Z Yang,Y Peng,W Dai,X Yu

1995-01-01

Abstract:In order to improve perfusion of coronary artery in case of coronary artery stenosis, effect of intra-aortic balloon pumping (IABP) on coronary blood flow (CBF) was investigated. To this end hemodynamic parameters of heart functions with and without stenosis were analysed under IABP. Hemodynamic effect of IABP was obviously influenced by the coronary artery stenosis.
Haemodynamic effects of intra‐aortic balloon pumps stratified by baseline pulmonary artery pulsatility index

George Kalapurakal,Vinh Q. Chau,Teruhiko Imamura,Sanika Tolia,Chris Sciamanna,Gregory P. Macaluso,Anjali Joshi,Jessica Pillarella,Sunil Pauwaa,Muhyaldeen Dia,Tarek Kabbany,James Monaco,Mark Dela Cruz,William G. Cotts,Patroklos Pappas,Antone J. Tatooles,Nikhil Narang

DOI: https://doi.org/10.1002/ehf2.15083

2024-09-20

ESC Heart Failure

Abstract:Aims Intra‐aortic balloon pump (IABP) devices are commonly used in patients with heart failure related cardiogenic shock (HF‐CS), including those with out‐of‐proportion right ventricular (RV) dysfunction. Pulmonary artery pulsatility index (PAPi) is a haemodynamic surrogate for RV performance. We aimed to assess short‐term haemodynamic changes in patients with HF‐CS following IABP support stratified by baseline PAPi. Methods and results This is a single‐centre study of 67 consecutive patients with HF‐CS who underwent IABP placement between 2020 and 2022. The primary aim was haemodynamic changes of specific variables on pulmonary artery catheter monitoring over 72 h following IABP placement. Secondary aims were clinically significant changes in diuretic regimens, changes in inotropes or vasopressors at 72 h following IABP, along with clinical outcomes. Prior to IABP placement, 57% of the total cohort (median age 59 years [48, 69], 31% female) had Society of Cardiovascular Angiography and Interventions Stage C HF‐CS. Thirty‐eight (56%) patients had a PAPi <2.0. Following 72 h of IABP support, the PAPi <2.0 group had an observed significant decrease in central venous pressure (CVP; 20 to 12 mmHg, P

cardiac & cardiovascular systems
Vascular complications following intra-aortic balloon pump implantation: an updated review

Monique M de Jong,Roberto Lorusso,Fatima Al Awami,Francesco Matteuci,Orlando Parise,Pieter Lozekoot,Massimo Bonacchi,Jos G Maessen,Daniel M Johnson,Sandro Gelsomino

DOI: https://doi.org/10.1177/0267659117727825

2017-08-17

Perfusion

Abstract:Background: The use of the intra-aortic balloon pump (IABP) as a support device remains controversial due to the fact that a number of studies have shown no benefit in end mortality whilst using this device. One of the reasons for this could be the increase in vascular complications when using the pump. Therefore, the aim of the present review was to assess the current literature available with regards to IABP vascular complications during the clinical situation. Methods: A literature search was performed, searching for IABP complications in adult human studies between 1990 and 2016. Results: A total of 20 reports were identified as fitting the criteria of this study. The majority of vascular complications were limb ischemia, bleeding or mesenteric ischemia. The overall incidence of vascular complications ranged from 0.94% to 31.1%. Diabetes, peripheral vascular disease and hypertension, as well as smoking were all identified as risk factors for complications following IABP. Furthermore, studies supported the use of sheathless balloon insertion to reduce the risk of complications. Conclusion: Major vascular complications, including limb and mesenteric ischemia as well as bleeding and hemorrhage, have been associated with IABP. However, the incidence of these complications was generally low. Further studies are still required to truly understand the risk/benefit associated with the use of IABP.
[Clinical Efficacy of Intra-Aortic Balloon Pumping in Treating Patients with Acute Myocardial Infarction with Left Main Coronary Artery Disease].

Xin Zhao,Ya-ling Han,Shou-li Wang,Xiao-zeng Wang,Quan-min Jing,Bin Wang,Geng Wang,Ying-yan Ma,Hai-wei Liu

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2012.38.007

2012-01-01

Abstract:OBJECTIVE:To evaluate the efficacy and safety of intra-aortic balloon pump (IABP) counter pulsation in the treatment of ST-segment elevation myocardial infarction (STEMI) with concurrent left main coronary artery (LMCA) disease.METHODS:A retrospective analysis was performed on 305 patients with confirmed STEMI due to LMCA occlusion (≥ 50%) by coronary angiography. They were divided into IABP and non-IABP groups according to the application of IABP or not. Two groups were further divided into 2 subgroups according to the treatment with percutaneous coronary intervention (PCI) or drug alone. Short and long-term clinical efficacies and the incidence of complications caused by the application of IABP were analyzed in all groups and subgroups.RESULTS:(1) PCI procedure: Successful rate of immediate post-procedure was 100%. No death, major cardiovascular event and cerebrovascular accident occurred during the procedure. The average number of stents per patient was 2.1 ± 0.7 and the average diameter and length of stent were (3.9 ± 0.6) and (24.2 ± 7.1) mm respectively. (2) SAFETY: No significant difference existed between the IABP and non-IABP groups in in-hospital massive bleeding rate (0.94% vs 1.00%, P > 0.05). However, the IABP group had a higher prevalence of mild in-hospital bleeding than the non-IABP group. (3) In-hospital and long-term major adverse cardiac event (MACE) rate: (1) IABP group had a lower MACE rate (25.3% (24/95) vs 38.5% (57/148), P < 0.05). (2) In spite of IABP implantation, the PCI subgroup had significantly a lower mortality rate than the drug subgroup (7.2% (6/83) vs 25.0% (6/24), P < 0.05). (3) The combined use of PCI and IABP was superior to other regimens with regards to decreasing short and long-term mortality (11.2% (12/107) and 25.3% (50/198), P < 0.01).CONCLUSION:PCI is feasible and safe for the STEMI patients with LMCA and better short and long-term efficacies may be achieved. The use of IABP in the treatment of LMCA-related STEMI reduces MACE rate and improves survival rate.

Experience with intraaortic balloon counterpulsation.

Application of intraaortic balloon counterpulsation during primary percutaneous coronary intervention in patients with cardiogenic shock complicating with acute myocardial infarction

Clinical evaluation of intra aortic balloon couterpulsation in percutaneous coronary interention for patients with acute myocardial infarction combined with cardiogenic shock

Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications

Aortic counterpulsation in cardiogenic shock during acute myocardial infarction

Clinical analysis of 33 patients with acute myocardial infarction implanted with intra-aortic balloon counterpulsation

A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery

Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock

The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study

Intra-aortic balloon pump: Looking at the other side

Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment.

Intraoperative intra-aortic balloon pump insertion: step by step

Staying in touch with methylphenidate: AHDH and sensory processing. Focus on "methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats".

Protracted aortic valve closure during peripheral veno-arterial extracorporeal life support: is intra-aortic balloon pump an effective solution?

Salutary Effects of the PULVAD, a Novel Implantable Counterpulsation Assist Device, on Cardiac Mechanoenergetics

Application of intra-aortic balloon pump in acute myocardial infarction complicared with cardiogenic shock undergoing percutaneous coronary intervention

Clinical Application of Intra-Aortic Balloon Counterpulsation in Patients with Acute Myocardial Infarction

[The Effect of Intra-Aortic Balloon Pumping in Case of Left Main Coronary Artery Stenosis].

Haemodynamic effects of intra‐aortic balloon pumps stratified by baseline pulmonary artery pulsatility index

Vascular complications following intra-aortic balloon pump implantation: an updated review

[Clinical Efficacy of Intra-Aortic Balloon Pumping in Treating Patients with Acute Myocardial Infarction with Left Main Coronary Artery Disease].